Literature DB >> 35459532

Respiratory effects of thyrotropin-releasing hormone and its analogue taltirelin on opioid-induced respiratory depression.

Marijke H Algera1, Joseph F Cotten2, Monique van Velzen1, Marieke Niesters1, Martijn Boon1, Daniel S Shoham2, Kaye E Dandrea2, Rutger van der Schrier1, Albert Dahan3.   

Abstract

Entities:  

Keywords:  electromyography; opioid-induced respiratory depression; respiratory depression; taltirelin; thyrotropin-releasing hormone

Mesh：

Substances：

Year:  2022        PMID： 35459532      PMCID： PMC9428912          DOI： 10.1016/j.bja.2022.03.022

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   11.719


× No keyword cloud information.
  10 in total

1.  The pre-Bötzinger complex participates in generating the respiratory effects of thyroliberin.

Authors:  A N Inyushkin; N A Merkulova; S A Chepurnov
Journal:  Neurosci Behav Physiol       Date:  1999 May-Jun

Review 2.  Novel thyrotropin-releasing hormone analogs: a patent review.

Authors:  Kailas S Khomane; Chhuttan L Meena; Rahul Jain; Arvind K Bansal
Journal:  Expert Opin Ther Pat       Date:  2011-11       Impact factor: 6.674

Review 3.  Thyrotropin-releasing hormone receptors -- similarities and differences.

Authors:  Y Sun; X Lu; M C Gershengorn
Journal:  J Mol Endocrinol       Date:  2003-04       Impact factor: 5.098

4.  Intravenous and Intratracheal Thyrotropin Releasing Hormone and Its Analog Taltirelin Reverse Opioid-Induced Respiratory Depression in Isoflurane Anesthetized Rats.

Authors:  James D Boghosian; Anita Luethy; Joseph F Cotten
Journal:  J Pharmacol Exp Ther       Date:  2018-04-19       Impact factor: 4.030

5.  Esketamine counters opioid-induced respiratory depression.

Authors:  K Jonkman; E van Rijnsoever; E Olofsen; L Aarts; E Sarton; M van Velzen; M Niesters; A Dahan
Journal:  Br J Anaesth       Date:  2018-03-26       Impact factor: 9.166

6.  Dexmedetomidine, acting through central alpha-2 adrenoceptors, prevents opiate-induced muscle rigidity in the rat.

Authors:  M B Weinger; I S Segal; M Maze
Journal:  Anesthesiology       Date:  1989-08       Impact factor: 7.892

Review 7.  The thyrotropin-releasing hormone (TRH) hypothesis of homeostatic regulation: implications for TRH-based therapeutics.

Authors:  Keith A Gary; Kevin A Sevarino; George G Yarbrough; Arthur J Prange; Andrew Winokur
Journal:  J Pharmacol Exp Ther       Date:  2003-02-20       Impact factor: 4.030

8.  Thyrotropin-releasing hormone has stimulatory effects on ventilation in humans.

Authors:  M Nink; U Krause; H Lehnert; W Heuberger; I Huber; R Schulz; G Hommel; J Beyer
Journal:  Acta Physiol Scand       Date:  1991-03

9.  Advances in Reversal Strategies of Opioid-induced Respiratory Toxicity.

Authors:  Rutger van der Schrier; Jack D C Dahan; Martijn Boon; Elise Sarton; Monique van Velzen; Marieke Niesters; Albert Dahan
Journal:  Anesthesiology       Date:  2022-04-01       Impact factor: 7.892

10.  A Comparison of Breathing Stimulants for Reversal of Synthetic Opioid-Induced Respiratory Depression in Conscious Rats.

Authors:  Kaye E Dandrea; Joseph F Cotten
Journal:  J Pharmacol Exp Ther       Date:  2021-05-21       Impact factor: 4.402
  10 in total
  1 in total

Review 1.  Are thyrotropin-releasing hormone (TRH) and analog taltirelin viable reversal agents of opioid-induced respiratory depression?

Authors:  Marieke Hyke Algera; Joseph F Cotten; Monique van Velzen; Marieke Niesters; Martijn Boon; Daniel S Shoham; Kaye E Dandrea; Rutger van der Schrier; Albert Dahan
Journal:  Pharmacol Res Perspect       Date:  2022-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.